Pre-Exercise Hyperventilation Effects on Wingate Test

Acute Effects of Pre-Exercise Voluntary Hyperventilation on Ventilatory Kinetics and Anaerobic Performance During a 30-s Wingate Test

Status

Completed

Phases

Unknown

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT07797205

Enrollment

Registered

2026-09-01

Start date

2026-02-11

Completion date

2026-02-25

Last updated

2026-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaerobic Performance

Keywords

Wingate Anaerobic Test, Respiratuar Alkalosis, Power Output, Fatigue

Brief summary

This study investigates the acute effects of pre-exercise voluntary hyperventilation on pulmonary gas exchange, cardiovascular responses, and anaerobic performance during a 30-second Wingate test in athletic males using a randomized crossover design.

Detailed description

Background The purpose of this study was to examine how hyperventilation (HV) affected pulmonary gas exchange, cardiovascular responses, and supramaximal performance during a 30-second Wingate Anaerobic Test (WAnT). Methods In a randomized crossover design, 18 athletic males completed both a control session and an HV session (30 breaths/min for 2 min prior to the WAnT).

Interventions

OTHERPre-exercise Voluntary Hyperventilation

Participants performed voluntary hyperventilation at a rate of 30 breaths/min for 2 minutes prior to the 30-second Wingate anaerobic test.

OTHERControl Conditions

Participants performed the 30-second Wingate test under control conditions without pre-exercise hyperventilation.

Study design

Allocation

RANDOMIZED

Intervention model

CROSSOVER

Primary purpose

BASIC_SCIENCE

Masking

NONE

Eligibility

Sex/Gender

MALE

Age

18 Years to 26 Years

Healthy volunteers

Yes

Inclusion criteria

* Being a healthy male competitive athlete aged 18-26 years * Having at least three years of consistent anaerobic training experience * Being a nonsmoker

Exclusion criteria

* Having any cardiovascular, musculoskeletal, neurological, or pulmonary disorders

Design outcomes

Primary

Measure	Time frame
Peak Power Output and Mean Power Output during the 30-second Wingate test	During the 30-second Wingate test

Secondary

Measure	Time frame
Pulmonary Gas Exchange responses during the 30-second Wingate test (measured via COSMED Quark CPET system)	During the 30-second Wingate test
Heart Rate Responses during the 30-second Wingate test (measured via COSMED Quark CPET system)	During the 30-second Wingate test

Countries

Turkey (Türkiye)

Contacts

PRINCIPAL_INVESTIGATORERKAN GUNAY, Prof.Dr.

Manisa Celal Bayar University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 2, 2026